日本指南的英语版本,用于治疗亚形性皮肤炎的生物药物
Hidehisa Saeki1, Masashi Akiyama2, Masatoshi Abe3
1Department of Dermatology, Nippon Medical School, Tokyo, Japan.
The Journal of dermatology
|August 31, 2023
概括
本指南提供了使用生物药物治疗阿托皮性皮肤炎 (AD) 的建议. 它强调了解药物的有效性,安全性和患者因素,以进行最佳的治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托匹性皮肤炎 (AD) 的发病过程涉及IL-4,IL-13和IL-31通路.
- 针对这些途径的生物药物,如dupilumab,nemolizumab和tralokinumab,已被批准用于AD治疗.
- 最佳使用需要了解疾病和患者因素.
研究的目的:
- 为提供关于使用生物药物治疗阿托皮性皮肤炎 (AD) 的英语指南.
- 确保医生理解并遵守日本卫生,劳工和福利部的指导方针.
- 促进在AD治疗中最佳和个性化地使用生物疗法.
主要方法:
- 本文档是日本临床指南的英语翻译.
- 它综合了关于已批准的生物制剂及其作用机制的信息.
- 它概述了基于疾病活性,药物特性和患者特征选择治疗的考虑因素.
主要成果:
- 已批准的生物药物包括dupilumab (抗IL-4受体α),nemolizumab (抗IL-31受体α) 和tralokinumab (抗IL-13).
- 治疗决策应综合疾病因素 (活性,严重程度),治疗因素 (有效性,安全性,剂量) 和患者背景 (年龄,并发症).
- 与患者共享决策对于选择适当的生物疗法至关重要.
结论:
- 医生必须遵守在亚托皮性皮肤炎中最佳使用生物药物的指导方针.
- 考虑多种因素的个性化治疗计划对于生物药物有效的AD管理至关重要.
- 本指南旨在支持经过董事会认证的皮肤科医生正确应用AD的生物疗法.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
149
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
149
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342